✦ LIBER ✦

A Phase 2 Study of Erlotinib (ERL) and Hypofractionated Thoracic Radiation Therapy (HRT) in Patients (Pts) With Non-Small Cell Lung Cancer (NSCLC) and Comorbidities

✍ Scribed by Werner-Wasik, M.; Pequignot, E.; Campling, B.; Shi, W.; Bhatia, A.; Wang, Z.; Shipman, K.; Dougherty, E.; Myers, C.; Axelrod, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic (PK) study o

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB

6513 ORAL A phase II study of erlotinib

✍ Dingemans, A.; Groen, H.J.M.; Smit, E.F. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Primarily Analysis of Radiation Pneumoni

✍ Zhuang, H.; Yuan, Z.; Wang, J.; Zhao, L.; Wang, P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A phase I–II study of docetaxel (D) and

✍ Quantin, X; Rebattu, P; Pujol, J; Morere, J; Azarian, M.R; Khial, F; Dumortier, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

A phase I/II study of twice-weekly gemci

✍ A.W. Blackstock; G.J. Lesser; J. Fletcher-Steede; L.D. Case; R.W. Tucker; S.M. R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Phase I study of weekly cisplatin, vinor

✍ Masashi Kobayashi; Kaoru Matsui; Tomonori Hirashima; Takashi Nitta; Shinji Sasad 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 226 KB